An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati S.p.A. has updated its share buyback program, which began in November 2024, to support its stock options and performance shares plans. The company purchased 78,762 ordinary shares in late February 2025, holding 2,803,193 shares by the end of the month, representing 1.340% of its share capital.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, and operates in about 150 countries across EMEA, Americas, and APAC regions with over 4,450 employees.
YTD Price Performance: 7.21%
Average Trading Volume: 34,093
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €11.2B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.